Original
Uso de la onabotulinumtoxina A en pacientes con vejiga hiperactiva idiopática con falta de eficacia, intolerancia o contraindicación para los anticolinérgicos
Use of onabotulinum toxin A in patients with idiopathic overactive bladder and a lack of efficacy, intolerance or contraindication with anticholinergics
Irma Amparo Ospina-Galeano
, José Medina-Polo, Susana de la Rosa-Kerhmann, Felipe Villacampa-Aubá, Felix Guerrero-Ramos, Juan Bautista Passas-Martínez
Autor para correspondencia
Departamento de Urología, Hospital Universitario 12 de Octubre, Madrid, España
Leído
6599
Vecesse ha leído el artículo
1265
Total PDF
5334
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 25 | 9 | 34 |
| 2025 11 | 83 | 26 | 109 |
| 2025 10 | 77 | 11 | 88 |
| 2025 9 | 66 | 13 | 79 |
| 2025 8 | 78 | 4 | 82 |
| 2025 7 | 65 | 13 | 78 |
| 2025 6 | 54 | 6 | 60 |
| 2025 5 | 73 | 3 | 76 |
| 2025 4 | 89 | 4 | 93 |
| 2025 3 | 77 | 7 | 84 |
| 2025 2 | 58 | 7 | 65 |
| 2025 1 | 54 | 2 | 56 |
| 2024 12 | 64 | 2 | 66 |
| 2024 11 | 68 | 6 | 74 |
| 2024 10 | 76 | 7 | 83 |
| 2024 9 | 83 | 6 | 89 |
| 2024 8 | 53 | 5 | 58 |
| 2024 7 | 79 | 4 | 83 |
| 2024 6 | 81 | 5 | 86 |
| 2024 5 | 79 | 3 | 82 |
| 2024 4 | 93 | 8 | 101 |
| 2024 3 | 106 | 9 | 115 |
| 2024 2 | 124 | 1 | 125 |
| 2024 1 | 111 | 8 | 119 |
| 2023 12 | 69 | 12 | 81 |
| 2023 11 | 78 | 13 | 91 |
| 2023 10 | 101 | 7 | 108 |
| 2023 9 | 66 | 28 | 94 |
| 2023 8 | 61 | 11 | 72 |
| 2023 7 | 70 | 6 | 76 |
| 2023 6 | 63 | 8 | 71 |
| 2023 5 | 74 | 6 | 80 |
| 2023 4 | 75 | 4 | 79 |
| 2023 3 | 74 | 9 | 83 |
| 2023 2 | 68 | 5 | 73 |
| 2022 1 | 52 | 8 | 60 |
| 2022 12 | 46 | 7 | 53 |
| 2022 11 | 50 | 10 | 60 |
| 2022 10 | 38 | 11 | 49 |
| 2022 9 | 48 | 11 | 59 |
| 2022 8 | 40 | 9 | 49 |
| 2022 7 | 41 | 7 | 48 |
| 2022 6 | 42 | 7 | 49 |
| 2022 5 | 59 | 6 | 65 |
| 2022 4 | 47 | 7 | 54 |
| 2022 3 | 111 | 7 | 118 |
| 2022 2 | 138 | 5 | 143 |
| 2021 1 | 98 | 5 | 103 |
| 2021 12 | 66 | 9 | 75 |
| 2021 11 | 59 | 7 | 66 |
| 2021 10 | 45 | 10 | 55 |
| 2021 9 | 44 | 5 | 49 |
| 2021 8 | 37 | 9 | 46 |
| 2021 7 | 44 | 9 | 53 |
| 2021 6 | 29 | 6 | 35 |
| 2021 5 | 30 | 8 | 38 |
| 2021 4 | 95 | 13 | 108 |
| 2021 3 | 56 | 15 | 71 |
| 2021 2 | 31 | 9 | 40 |
| 2020 1 | 26 | 11 | 37 |
| 2020 12 | 21 | 7 | 28 |
| 2020 11 | 18 | 14 | 32 |
| 2020 10 | 19 | 8 | 27 |
| 2020 9 | 21 | 11 | 32 |
| 2020 8 | 32 | 5 | 37 |
| 2020 7 | 22 | 7 | 29 |
| 2020 6 | 14 | 7 | 21 |
| 2020 5 | 25 | 10 | 35 |
| 2020 4 | 24 | 6 | 30 |
| 2020 3 | 36 | 15 | 51 |
| 2020 2 | 37 | 12 | 49 |
| 2020 1 | 24 | 8 | 32 |
| 2019 12 | 15 | 12 | 27 |
| 2019 11 | 14 | 13 | 27 |
| 2019 10 | 32 | 4 | 36 |
| 2019 9 | 43 | 18 | 61 |
| 2019 8 | 40 | 6 | 46 |
| 2019 7 | 24 | 7 | 31 |
| 2019 6 | 49 | 31 | 80 |
| 2019 5 | 109 | 60 | 169 |
| 2019 4 | 56 | 42 | 98 |
| 2019 3 | 14 | 12 | 26 |
| 2019 2 | 22 | 23 | 45 |
| 2019 1 | 11 | 14 | 25 |
| 2018 12 | 21 | 22 | 43 |
| 2018 11 | 15 | 18 | 33 |
| 2018 10 | 16 | 7 | 23 |
| 2018 9 | 14 | 14 | 28 |
| 2018 8 | 18 | 14 | 32 |
| 2018 7 | 9 | 20 | 29 |
| 2018 6 | 10 | 10 | 20 |
| 2018 5 | 11 | 10 | 21 |
| 2018 4 | 17 | 7 | 24 |
| 2018 3 | 5 | 1 | 6 |
| 2018 2 | 14 | 5 | 19 |
| 2018 1 | 13 | 4 | 17 |
| 2017 12 | 8 | 3 | 11 |
| 2017 11 | 10 | 6 | 16 |
| 2017 10 | 5 | 11 | 16 |
| 2017 9 | 7 | 6 | 13 |
| 2017 8 | 7 | 4 | 11 |
| 2017 7 | 6 | 14 | 20 |
| 2017 6 | 10 | 3 | 13 |
| 2017 5 | 7 | 7 | 14 |
| 2017 4 | 5 | 21 | 26 |
| 2017 3 | 15 | 40 | 55 |
| 2017 2 | 5 | 7 | 12 |
| 2016 1 | 9 | 8 | 17 |
| 2016 12 | 28 | 8 | 36 |
| 2016 11 | 36 | 16 | 52 |
| 2016 10 | 33 | 14 | 47 |
| 2016 9 | 52 | 10 | 62 |
| 2016 8 | 42 | 17 | 59 |
| 2016 7 | 50 | 2 | 52 |
| 2016 6 | 52 | 40 | 92 |
| 2016 5 | 39 | 31 | 70 |
| 2016 4 | 36 | 24 | 60 |
Mostrar todo